vanoxerine has been researched along with ro 60-0175 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cathala, A; Drago, F; Leggio, GM; Neny, M; Piazza, PV; Rouge-Pont, F; Spampinato, U | 1 |
1 other study(ies) available for vanoxerine and ro 60-0175
| Article | Year |
|---|---|
In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Topics: Aminopyridines; Analgesics, Opioid; Animals; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Ethylamines; Extracellular Space; Haloperidol; Indoles; Male; Microdialysis; Microinjections; Morphinans; Neural Pathways; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |